loader from loading.io

Implantable Pump Transforms Treatment for Liver Disease with Ian Crosbie Sequana Medical TRANSCRIPT

Empowered Patient Podcast

Release Date: 03/10/2026

AI-Powered Diagnostic Platform Connects Medical Specialists and Patients to Solve Complex Healthcare Cases with Haresh Patel Diagnostic MD AI TRANSCRIPT show art AI-Powered Diagnostic Platform Connects Medical Specialists and Patients to Solve Complex Healthcare Cases with Haresh Patel Diagnostic MD AI TRANSCRIPT

Empowered Patient Podcast

Haresh Patel, Founder of Diagnostic MD AI, discusses the transformative potential of AI in healthcare diagnostics, particularly for patients with chronic or complex issues. Based on his own struggle to get an accurate diagnosis of an autoimmune condition, Haresh has developed a patient-centric platform where individuals can build their complete health story, integrating modern and functional medicine with a more holistic approach, which AI analyzes to help doctors connect disparate symptoms, ask the right questions, identify patterns, and reach the correct diagnosis faster while reducing...

info_outline
AI-Powered Diagnostic Platform Connects Medical Specialists and Patients to Solve Complex Healthcare Cases with Haresh Patel Diagnostic MD AI show art AI-Powered Diagnostic Platform Connects Medical Specialists and Patients to Solve Complex Healthcare Cases with Haresh Patel Diagnostic MD AI

Empowered Patient Podcast

Haresh Patel, Founder of Diagnostic MD AI, discusses the transformative potential of AI in healthcare diagnostics, particularly for patients with chronic or complex issues. Based on his own struggle to get an accurate diagnosis of an autoimmune condition, Haresh has developed a patient-centric platform where individuals can build their complete health story, integrating modern and functional medicine with a more holistic approach, which AI analyzes to help doctors connect disparate symptoms, ask the right questions, identify patterns, and reach the correct diagnosis faster while reducing...

info_outline
How EHR Systems Use Clinical AI to Advance Interoperability  with Ben Scharfe Altera Digital Health TRANSCRIPT show art How EHR Systems Use Clinical AI to Advance Interoperability with Ben Scharfe Altera Digital Health TRANSCRIPT

Empowered Patient Podcast

Ben Scharfe, Executive VP of AI at Altera Digital Health, addresses the evolving regulatory landscape for AI in healthcare, emphasizing AI developers' primary responsibility to ensure transparency so clinicians can understand and verify AI-generated outputs. AI is positioned to be a supportive tool for providers, not as an autonomous decision-maker, with emerging regulations beginning to codify the human-in-the-loop requirement. Ben warns of setting higher standards for AI than physicians and automation complacency, in which clinicians might over-rely on AI. Ben explains, "Altera provides...

info_outline
How EHR Systems Use Clinical AI to Advance Interoperability  with Ben Scharfe Altera Digital Health show art How EHR Systems Use Clinical AI to Advance Interoperability with Ben Scharfe Altera Digital Health

Empowered Patient Podcast

Ben Scharfe, Executive VP of AI at Altera Digital Health, addresses the evolving regulatory landscape for AI in healthcare, emphasizing AI developers' primary responsibility to ensure transparency so clinicians can understand and verify AI-generated outputs. AI is positioned to be a supportive tool for providers, not as an autonomous decision-maker, with emerging regulations beginning to codify the human-in-the-loop requirement. Ben warns of setting higher standards for AI than physicians and automation complacency, in which clinicians might over-rely on AI. Ben explains, "Altera provides...

info_outline
Hospital Medicine Group Utilizing AI to Enhance Value-Based Care with Dr. John Birkmeyer Sound Physicians TRANSCRIPT show art Hospital Medicine Group Utilizing AI to Enhance Value-Based Care with Dr. John Birkmeyer Sound Physicians TRANSCRIPT

Empowered Patient Podcast

Dr. John Birkmeyer, President of the medical group at Sound Physicians, defines value-based care as an evolution from older managed care models, with closer alignment of incentives for quality of care and cost-effectiveness. Working within the hospital environment, this approach emphasizes standardizing patient-centered care and communication across multiple hospital departments, reducing redundant tests and improving patient outcomes. The use of AI is one way to reduce the administrative burden on physicians, freeing up more time for patient care, a departure from earlier technologies that...

info_outline
Hospital Medicine Group Utilizing AI to Enhance Value-Based Care with Dr. John Birkmeyer Sound Physicians show art Hospital Medicine Group Utilizing AI to Enhance Value-Based Care with Dr. John Birkmeyer Sound Physicians

Empowered Patient Podcast

Dr. John Birkmeyer, President of the medical group at Sound Physicians, defines value-based care as an evolution from older managed care models, with closer alignment of incentives for quality of care and cost-effectiveness. Working within the hospital environment, this approach emphasizes standardizing patient-centered care and communication across multiple hospital departments, reducing redundant tests and improving patient outcomes. The use of AI is one way to reduce the administrative burden on physicians, freeing up more time for patient care, a departure from earlier technologies that...

info_outline
Extensive Myeloma Biobank Advancing Research in Blood Cancer Detection and Therapies with Dr. Jim Berenson Institute for Myeloma & Bone Cancer Research TRANSCRIPT show art Extensive Myeloma Biobank Advancing Research in Blood Cancer Detection and Therapies with Dr. Jim Berenson Institute for Myeloma & Bone Cancer Research TRANSCRIPT

Empowered Patient Podcast

Dr. Jim Berenson, Founder of the Institute for Myeloma & Bone Cancer Research and the Berenson Cancer Center, describes the Institute's work, which includes maintaining a large biobank of patient samples that support both its own research and that being conducted by external groups. This biobank is being used to develop new blood markers for faster disease diagnosis, to assess treatment efficacy, and to support drug development for multiple myeloma and other cancers. Real-time monitoring of patient symptoms with a mobile app is capturing critical, often-missed patient data and providing...

info_outline
Extensive Myeloma Biobank Advancing Research in Blood Cancer Detection and Therapies with Dr. Jim Berenson Institute for Myeloma & Bone Cancer Research show art Extensive Myeloma Biobank Advancing Research in Blood Cancer Detection and Therapies with Dr. Jim Berenson Institute for Myeloma & Bone Cancer Research

Empowered Patient Podcast

Dr. Jim Berenson, Founder of the Institute for Myeloma & Bone Cancer Research and the Berenson Cancer Center, describes the Institute's work, which includes maintaining a large biobank of patient samples that support both its own research and that being conducted by external groups. This biobank is being used to develop new blood markers for faster disease diagnosis, to assess treatment efficacy, and to support drug development for multiple myeloma and other cancers. Real-time monitoring of patient symptoms with a mobile app is capturing critical, often-missed patient data and providing...

info_outline
Next-Generation Imaging Catheter for Enhanced Coronary Interventions with Tom Looby Conavi TRANSCRIPT show art Next-Generation Imaging Catheter for Enhanced Coronary Interventions with Tom Looby Conavi TRANSCRIPT

Empowered Patient Podcast

Tom Looby, CEO of Conavi, is focused on developing hybrid intravascular imaging technology that combines two established modalities into a single imaging catheter to provide a comprehensive view of the coronary arteries. This eliminates blind spots when using either intravascular ultrasound (IVUS) or optical coherence tomography (OCT) alone and is driving a shift away from relying solely on traditional angiography toward the use of advanced intravascular imaging to guide coronary procedures. Using AI to analyze dual-stream co-registered data allows interventional cardiologists to more...

info_outline
Next-Generation Imaging Catheter for Enhanced Coronary Interventions with Tom Looby Conavi show art Next-Generation Imaging Catheter for Enhanced Coronary Interventions with Tom Looby Conavi

Empowered Patient Podcast

Tom Looby, CEO of Conavi, is focused on developing hybrid intravascular imaging technology that combines two established modalities into a single imaging catheter to provide a comprehensive view of the coronary arteries. This eliminates blind spots when using either intravascular ultrasound (IVUS) or optical coherence tomography (OCT) alone and is driving a shift away from relying solely on traditional angiography toward the use of advanced intravascular imaging to guide coronary procedures. Using AI to analyze dual-stream co-registered data allows interventional cardiologists to more...

info_outline
 
More Episodes

Ian Crosbie, CEO of Sequana Medical, identifies the incidence of liver cirrhosis and the complication of liver ascites, which causes significant fluid buildup in the belly that severely impacts a patient's quality of life. Standard treatment requires repeated hospital visits to drain the fluid. The alfapump developed by Sequana is a fully implanted device that continuously drains ascites into the bladder for natural excretion, eliminating the need for drainage procedures.

Ian explains, "Liver ascites is a complication of liver cirrhosis, a serious condition where the liver becomes badly scarred. As a result, the fluid accumulates in the belly, often five to ten liters of fluid. And as you can imagine, this causes huge swelling of the belly and major clinical problems, and obviously dramatically impacts the quality of life of these patients. Problems can include instability and falling. You can imagine with all that weight out front. The swelling of the belly causes difficulty eating, breathing, sleeping, and functioning." 

 "So we're in an era of AI and targeted cancer therapies, CAR-T, and things like that. But the standard of care for these patients is to let them build up five to ten liters of fluid in their bellies, then bring them into hospital, stick a big needle in them, drain them over the course of five to seven hours, send them away, and then the moment they leave hospital, they start to reaccumulate that fluid again, and the process starts all over. That is a procedure known as paracentesis. Not only is it, as you can imagine, a painful, burdensome, and traumatic procedure, but in the days leading up to the procedure, the days and weeks as the fluid starts to accumulate, all those impacts on quality of life and clinical complications occur. And so that is why we developed alfapump to stop the buildup of fluid in the belly and to stop all of those problems and to stop those regular visits to the hospital."

#SequanaMedical #MedicalDevices #LiverDisease #HealthcareInnovation #PatientCare #MedTech #Alfapump #DigitalHealth #ChronicDisease #QualityOfLife #HealthTech #MedicalBreakthrough

sequanamedical.com

Listen to the podcast here

Sequana